000 03850nam a22006495i 4500
001 978-981-97-3001-8
003 DE-He213
005 20250516160058.0
007 cr nn 008mamaa
008 240702s2024 si | s |||| 0|eng d
020 _a9789819730018
_9978-981-97-3001-8
050 4 _aRC261-271
072 7 _aMJCL
_2bicssc
072 7 _aMED062000
_2bisacsh
072 7 _aMJCL
_2thema
082 0 4 _a571.978
_223
082 0 4 _a616.994
_223
245 1 0 _aBiosimilars for Cancer Treatment
_h[electronic resource] :
_bA Promising Approach /
_cedited by Shvetank Bhatt, Harish Dureja, Samir Gunvantbhai Patel, Archita Samir Patel, Kamal Dua.
250 _a1st ed. 2024.
264 1 _aSingapore :
_bSpringer Nature Singapore :
_bImprint: Springer,
_c2024.
300 _aXVI, 309 p. 25 illus., 24 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _a1. An Overview of Biosimilars -- 2. Immunobiology of Cancer -- 3. Mechanism of Biosimilars for the treatment of Cancer -- 4. Biosimilars in Colorectal Cancer -- 5. Biosimilars in Cervical Caner -- 6. Biosimilars in Prostate Cancer -- 7. Biosimilars in Gastric Cancer -- 8. Biosimilars in Lung Cancer -- 9. A Recent Overview of The Growing Applications of Biosimilars in Pancreatic Cancer Management- Current Picture and Future Perspectives -- 10. Biosimilars in Breast Cancer -- 11. Biosimilars in Hepatocellular Carcinoma -- 12. Biosimilars in Ovarian Cancer -- 13. Biosimilars in Blood Cancer -- 14. Biosimilars in Clinical Trials -- 15. Regulatory Considerations of Biosimilars in Cancer -- 16. Future Scope of Biosimilars for the Treatment of Various Cancers.
520 _aThe book delves into the role of biosimilars in the field of cancer treatment. It also discusses the application of biosimilars in various cancer types, from colorectal and cervical to prostate, gastric, lung, pancreatic, breast, hepatocellular, ovarian, and blood cancers. It contains chapters that focus on the clinical trials of biosimilars, providing insights into the latest research and developments. This book serves as a valuable resource for clinicians, researchers, and anyone seeking a comprehensive understanding of the intersection between biosimilars and cancer treatment.
541 _fUABC ;
_cPerpetuidad
650 0 _aCancer.
650 0 _aBiology.
650 0 _aCancer
_xTreatment.
650 0 _aCancer
_xPrevention.
650 0 _aCancer
_xGenetic aspects.
650 1 4 _aCancer Biology.
650 2 4 _aBiological Sciences.
650 2 4 _aCancer Therapy.
650 2 4 _aCancers.
650 2 4 _aCancer Prevention.
650 2 4 _aCancer Genetics and Genomics.
700 1 _aBhatt, Shvetank.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aDureja, Harish.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aGunvantbhai Patel, Samir.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aSamir Patel, Archita.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aDua, Kamal.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
773 0 _tSpringer Nature eBook
776 0 8 _iPrinted edition:
_z9789819730001
776 0 8 _iPrinted edition:
_z9789819730025
776 0 8 _iPrinted edition:
_z9789819730032
856 4 0 _zLibro electrónico
_uhttp://libcon.rec.uabc.mx:2048/login?url=https://doi.org/10.1007/978-981-97-3001-8
912 _aZDB-2-SBL
912 _aZDB-2-SXB
942 _cLIBRO_ELEC
999 _c275565
_d275564